Sturm Ruger & Co., Inc. (RGR)
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-04
$38.49+3.41%
Close 2026-09-04 · 1-day change
NYSEIndustrialsAerospace & DefenseSnapshot 2026-09-04
Warn: Management is running behind on a stated commitment.
Ruger plans to spend $30 million on new products and upgrades. Sales should grow about 2% next year. The company has a strong brand in firearms. Management is improving after recent changes.
Industry problems could hurt Ruger's sales and profits. Recent earnings missed expectations. Lawsuits and management changes add risk.
The price is about 2% below our fair value near $39. Analysts expect about 2% revenue growth. We see risks in earnings and industry headwinds not fully priced.
Breaks if: CAPEX falls below $30 million in 2026
Continue capital expenditures totaling approximately $30 million for new product introductions, expanded capacity, upgraded manufacturing, and facility infrastructure.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on improving profitability and expanding product ecosystems. The current thesis is cautious due to mixed management execution and sector challenges.
The market appears to have priced in a justified valuation, though it is considered expensive compared to peers. There is a low expectations gap, indicating that investors are not overly optimistic about future performance.
Fundamentals may improve as management focuses on cost discipline and operational efficiency, which has shown some success. However, recent financial performance has been neutral, and there is a risk of missing future estimates.
The thesis hinges on the performance of sector bellwethers like SPCX, GE, and RTX. Positive earnings from these companies could support RGR, while negative guidance could create headwinds.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. Manufacturing improvements and product mix have driven growth. Profit increases support operational efficiency objectives. There are no new threats impacting the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Year-to-date capital expenditures totaled $8 million through 2026-Q2, with a full-year expectation of approximately $30 million for investments in new products, capacity expansion, and manufacturing upgrades. The trajectory is consistent with management's stated capital allocation plan.
“The Company expects capital expenditures to total approximately $30 million for the year for continued investments in new product introductions, expanded capacity, upgraded manufacturing capabilities…”
“The Company expects capital expenditures to total $30 million for the year for continued investments in new product introductions, expanded capacity, upgraded manufacturing capabilities and strengthe…”
Breaks if: Further disruptive management changes or poor execution news
Breaks if: Revenue growth falls below 2% in 2027
Overall, RGR's outlook is mixed, with a need for careful monitoring of both management execution and sector trends. Not investment advice.